Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol
Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdra...
Gespeichert in:
Veröffentlicht in: | Neuroscience 2003-01, Vol.121 (4), p.1063-1074 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1074 |
---|---|
container_issue | 4 |
container_start_page | 1063 |
container_title | Neuroscience |
container_volume | 121 |
creator | Fan, L.-W Tien, L.-T Tanaka, S Ma, T Chudapongse, N Sinchaisuk, S Rockhold, R.W Ho, I.K |
description | Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine. |
doi_str_mv | 10.1016/S0306-4522(03)00299-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_18952139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0306452203002999</els_id><sourcerecordid>18952139</sourcerecordid><originalsourceid>FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</originalsourceid><addsrcrecordid>eNqFkM1O3DAQgC1EBcvSR2jlC4geAv5N1ieEVtBWWqmHtmfLsSddo2yc2gkrXo2H6DPh7K7g2LnMjPTNjz6EPlFyTQktb34STspCSMauCP9CCFOqUEdoRhcVLyopxDGavSGn6CylR5JDCn6CTqmQC6JkOUPdcm26P5Cw7_CwBlxHk6t_L0XoffAOR7DQDyHiFp6gTTg0OJphh2_9sHbRbE2Lmxg2uF8_J29z56CHzkFnAY996HA95gV9vhPac_ShMW2Cj4c8R78f7n8tvxWrH1-_L-9WhRWMDYUEWtayIo5ZSZxiVKqa0KpSilJriVCVaGrlytIYQcEBNMCY4dRYZWQtFZ-jy_3ePoa_I6RBb3yy0LamgzAmTRdKMsonUO5BG0NKERrdR78x8VlToifReidaTxY14XonWk9znw8HxnoD7n3qYDYDFwfApCyliaazPr1zkpWE84m73XPZLjx5iDpZP7lzPrsftAv-P6-8Aki1nDA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18952139</pqid></control><display><type>article</type><title>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Fan, L.-W ; Tien, L.-T ; Tanaka, S ; Ma, T ; Chudapongse, N ; Sinchaisuk, S ; Rockhold, R.W ; Ho, I.K</creator><creatorcontrib>Fan, L.-W ; Tien, L.-T ; Tanaka, S ; Ma, T ; Chudapongse, N ; Sinchaisuk, S ; Rockhold, R.W ; Ho, I.K</creatorcontrib><description>Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.</description><identifier>ISSN: 0306-4522</identifier><identifier>EISSN: 1873-7544</identifier><identifier>DOI: 10.1016/S0306-4522(03)00299-9</identifier><identifier>PMID: 14580956</identifier><identifier>CODEN: NRSCDN</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Analgesics ; Animals ; Behavior, Animal - drug effects ; Biological and medical sciences ; Brain - drug effects ; Brain - metabolism ; butorphanol ; Butorphanol - adverse effects ; immunoblotting analysis ; Male ; Medical sciences ; morphine ; Morphine - adverse effects ; Naloxone - pharmacology ; Narcotic Antagonists - pharmacology ; Narcotics - adverse effects ; Neuropharmacology ; Opioid-Related Disorders - metabolism ; Opioid-Related Disorders - physiopathology ; Pharmacology. Drug treatments ; physical dependence ; Rats ; Rats, Sprague-Dawley ; Receptors, Opioid, kappa - drug effects ; Receptors, Opioid, kappa - metabolism ; Receptors, Opioid, mu - drug effects ; Receptors, Opioid, mu - metabolism ; Substance Withdrawal Syndrome - metabolism ; Substance Withdrawal Syndrome - physiopathology ; Up-Regulation - drug effects ; Up-Regulation - physiology ; withdrawal ; κ-opioid receptors</subject><ispartof>Neuroscience, 2003-01, Vol.121 (4), p.1063-1074</ispartof><rights>2003 IBRO</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</citedby><cites>FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0306-4522(03)00299-9$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15260336$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14580956$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fan, L.-W</creatorcontrib><creatorcontrib>Tien, L.-T</creatorcontrib><creatorcontrib>Tanaka, S</creatorcontrib><creatorcontrib>Ma, T</creatorcontrib><creatorcontrib>Chudapongse, N</creatorcontrib><creatorcontrib>Sinchaisuk, S</creatorcontrib><creatorcontrib>Rockhold, R.W</creatorcontrib><creatorcontrib>Ho, I.K</creatorcontrib><title>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</title><title>Neuroscience</title><addtitle>Neuroscience</addtitle><description>Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.</description><subject>Analgesics</subject><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Biological and medical sciences</subject><subject>Brain - drug effects</subject><subject>Brain - metabolism</subject><subject>butorphanol</subject><subject>Butorphanol - adverse effects</subject><subject>immunoblotting analysis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>morphine</subject><subject>Morphine - adverse effects</subject><subject>Naloxone - pharmacology</subject><subject>Narcotic Antagonists - pharmacology</subject><subject>Narcotics - adverse effects</subject><subject>Neuropharmacology</subject><subject>Opioid-Related Disorders - metabolism</subject><subject>Opioid-Related Disorders - physiopathology</subject><subject>Pharmacology. Drug treatments</subject><subject>physical dependence</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Receptors, Opioid, kappa - drug effects</subject><subject>Receptors, Opioid, kappa - metabolism</subject><subject>Receptors, Opioid, mu - drug effects</subject><subject>Receptors, Opioid, mu - metabolism</subject><subject>Substance Withdrawal Syndrome - metabolism</subject><subject>Substance Withdrawal Syndrome - physiopathology</subject><subject>Up-Regulation - drug effects</subject><subject>Up-Regulation - physiology</subject><subject>withdrawal</subject><subject>κ-opioid receptors</subject><issn>0306-4522</issn><issn>1873-7544</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1O3DAQgC1EBcvSR2jlC4geAv5N1ieEVtBWWqmHtmfLsSddo2yc2gkrXo2H6DPh7K7g2LnMjPTNjz6EPlFyTQktb34STspCSMauCP9CCFOqUEdoRhcVLyopxDGavSGn6CylR5JDCn6CTqmQC6JkOUPdcm26P5Cw7_CwBlxHk6t_L0XoffAOR7DQDyHiFp6gTTg0OJphh2_9sHbRbE2Lmxg2uF8_J29z56CHzkFnAY996HA95gV9vhPac_ShMW2Cj4c8R78f7n8tvxWrH1-_L-9WhRWMDYUEWtayIo5ZSZxiVKqa0KpSilJriVCVaGrlytIYQcEBNMCY4dRYZWQtFZ-jy_3ePoa_I6RBb3yy0LamgzAmTRdKMsonUO5BG0NKERrdR78x8VlToifReidaTxY14XonWk9znw8HxnoD7n3qYDYDFwfApCyliaazPr1zkpWE84m73XPZLjx5iDpZP7lzPrsftAv-P6-8Aki1nDA</recordid><startdate>20030101</startdate><enddate>20030101</enddate><creator>Fan, L.-W</creator><creator>Tien, L.-T</creator><creator>Tanaka, S</creator><creator>Ma, T</creator><creator>Chudapongse, N</creator><creator>Sinchaisuk, S</creator><creator>Rockhold, R.W</creator><creator>Ho, I.K</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>20030101</creationdate><title>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</title><author>Fan, L.-W ; Tien, L.-T ; Tanaka, S ; Ma, T ; Chudapongse, N ; Sinchaisuk, S ; Rockhold, R.W ; Ho, I.K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c422t-5e16b570d2c50d92159b01779911cc04974fb9d66aa41edeefe22a31ac9a5b593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Analgesics</topic><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Biological and medical sciences</topic><topic>Brain - drug effects</topic><topic>Brain - metabolism</topic><topic>butorphanol</topic><topic>Butorphanol - adverse effects</topic><topic>immunoblotting analysis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>morphine</topic><topic>Morphine - adverse effects</topic><topic>Naloxone - pharmacology</topic><topic>Narcotic Antagonists - pharmacology</topic><topic>Narcotics - adverse effects</topic><topic>Neuropharmacology</topic><topic>Opioid-Related Disorders - metabolism</topic><topic>Opioid-Related Disorders - physiopathology</topic><topic>Pharmacology. Drug treatments</topic><topic>physical dependence</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Receptors, Opioid, kappa - drug effects</topic><topic>Receptors, Opioid, kappa - metabolism</topic><topic>Receptors, Opioid, mu - drug effects</topic><topic>Receptors, Opioid, mu - metabolism</topic><topic>Substance Withdrawal Syndrome - metabolism</topic><topic>Substance Withdrawal Syndrome - physiopathology</topic><topic>Up-Regulation - drug effects</topic><topic>Up-Regulation - physiology</topic><topic>withdrawal</topic><topic>κ-opioid receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fan, L.-W</creatorcontrib><creatorcontrib>Tien, L.-T</creatorcontrib><creatorcontrib>Tanaka, S</creatorcontrib><creatorcontrib>Ma, T</creatorcontrib><creatorcontrib>Chudapongse, N</creatorcontrib><creatorcontrib>Sinchaisuk, S</creatorcontrib><creatorcontrib>Rockhold, R.W</creatorcontrib><creatorcontrib>Ho, I.K</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fan, L.-W</au><au>Tien, L.-T</au><au>Tanaka, S</au><au>Ma, T</au><au>Chudapongse, N</au><au>Sinchaisuk, S</au><au>Rockhold, R.W</au><au>Ho, I.K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol</atitle><jtitle>Neuroscience</jtitle><addtitle>Neuroscience</addtitle><date>2003-01-01</date><risdate>2003</risdate><volume>121</volume><issue>4</issue><spage>1063</spage><epage>1074</epage><pages>1063-1074</pages><issn>0306-4522</issn><eissn>1873-7544</eissn><coden>NRSCDN</coden><abstract>Changes in κ-opioid receptor levels have been implicated in the development of physical dependence upon and withdrawal from the mixed agonist–antagonist opioid, butorphanol. Immunoblotting analysis was performed to determine the levels of κ- and μ-opioid receptors in brain regions of rats in withdrawal from dependence upon butorphanol or morphine. Physical dependence was induced by a 72 h i.c.v. infusion with either butorphanol or morphine (26 nmol/μl/h). Withdrawal was subsequently precipitated by i.c.v. challenge with naloxone (48 nmol/5 μl/rat), administered 2 h following cessation of butorphanol or morphine infusion. Immunoblotting analysis of κ-opioid receptors from butorphanol-withdrawal rats showed significant increases in 11 of 21 brain regions examined, including the nucleus accumbens, amygdala, dorsomedial hypothalamus, hypothalamus, paraventricular thalamus, thalamus, presubiculum, and locus coeruleus, when compared with saline treated, non-dependent controls. In addition, significant reductions were found in the hippocampus and in cortical brain regions, including the parietal cortex and temporal cortex from butorphanol-withdrawal rats. These findings contrasted with those from morphine-withdrawal rats, in which the only changes noted were increases in the thalamus and paraventricular thalamus. Changes in the levels of the μ-opioid receptor protein were observed in 11 of 21 brain regions examined in morphine-withdrawal rats, but only in three of 21 in butorphanol-withdrawal rats. These results implicate a substantive and largely unique role for κ-opioid receptors in mediation of the development of physical dependence upon, and the expression of withdrawal from, butorphanol, as opposed to the prototypical opioid analgesic, morphine.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>14580956</pmid><doi>10.1016/S0306-4522(03)00299-9</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0306-4522 |
ispartof | Neuroscience, 2003-01, Vol.121 (4), p.1063-1074 |
issn | 0306-4522 1873-7544 |
language | eng |
recordid | cdi_proquest_miscellaneous_18952139 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | Analgesics Animals Behavior, Animal - drug effects Biological and medical sciences Brain - drug effects Brain - metabolism butorphanol Butorphanol - adverse effects immunoblotting analysis Male Medical sciences morphine Morphine - adverse effects Naloxone - pharmacology Narcotic Antagonists - pharmacology Narcotics - adverse effects Neuropharmacology Opioid-Related Disorders - metabolism Opioid-Related Disorders - physiopathology Pharmacology. Drug treatments physical dependence Rats Rats, Sprague-Dawley Receptors, Opioid, kappa - drug effects Receptors, Opioid, kappa - metabolism Receptors, Opioid, mu - drug effects Receptors, Opioid, mu - metabolism Substance Withdrawal Syndrome - metabolism Substance Withdrawal Syndrome - physiopathology Up-Regulation - drug effects Up-Regulation - physiology withdrawal κ-opioid receptors |
title | Changes in the brain κ-opioid receptor levels of rats in withdrawal from physical dependence upon butorphanol |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A10%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20in%20the%20brain%20%CE%BA-opioid%20receptor%20levels%20of%20rats%20in%20withdrawal%20from%20physical%20dependence%20upon%20butorphanol&rft.jtitle=Neuroscience&rft.au=Fan,%20L.-W&rft.date=2003-01-01&rft.volume=121&rft.issue=4&rft.spage=1063&rft.epage=1074&rft.pages=1063-1074&rft.issn=0306-4522&rft.eissn=1873-7544&rft.coden=NRSCDN&rft_id=info:doi/10.1016/S0306-4522(03)00299-9&rft_dat=%3Cproquest_cross%3E18952139%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=18952139&rft_id=info:pmid/14580956&rft_els_id=S0306452203002999&rfr_iscdi=true |